为更好地服务国家创新驱动发展战略和健康中国战略，泰康保险集团于2021年向武汉大学捐赠10亿元人民币，以支持武汉大学医学与生命科学发展。在此基础上，2021年12月31日成立武汉大学泰康生命医学中心（以下简称中心）。

中心为武汉大学校内独立运行的实体科研机构，由中国科学院院士、著名代谢生物学家宋保亮教授出任中心主任、首席科学家。中心主要任务是以卓越的生命医学研究带动拔尖创新人才培养，建设国际一流的科学研究与人才培养高地。中心采用国际先进的管理和运行机制，设立科学咨询委员会，采用现代科技PI制度（首席学术带头人+团队），组建高水平科研团队。中心建设有一流的公共科研平台和大型共享设备，聚焦健康与疾病相关的重大科学问题开展前沿探索，为重大疾病的治疗提供源头创新，持续提升我国医学与生命科学领域的创新能力。

To better serve the national innovation-driven development strategy and the Healthy China strategy, Taikang Insurance Group donated 1 billion RMB to Wuhan University in 2021 to support the development in medical and life sciences at Wuhan University. Starting from this initiative, on December 31, 2021, the Taikang Center for Life and Medical Sciences (hereinafter referred to as “Taikang Center") was established.

Taikang Center is an independently operated research institution in Wuhan University. It is led by Professor Song Bao-Liang, a renowned metabolic biologist and academician of the Chinese Academy of Sciences, who serves as the Director and Chief Scientist of Taikang Center. The primary mission of Taikang Center is to drive the cultivation of top innovative talents through outstanding research in life and medical sciences, aiming to build an world-class highland for scientific research and talent cultivation. Taikang Center adopts internationally advanced management and operation mechanisms, establishes a scientific advisory committee, and employs a modern scientific Principal Investigator (PI) system (a Chief Academic Leader + a team) to assemble high-level research groups. Taikang Center has established a full set of core facilities with advanced large equipment. It focuses on cutting-edge exploration of significantly scientific questions related to health and diseases, provides pioneering innovations for the treatment of major diseases, and continuously contributes to improve China's innovation capabilities in the fields of medical and life sciences.